BIOCRYST PHARMACEUTICALS, INC. Inventory, Work in Process, Net of Reserves
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Inventory, Work in Process, Net of Reserves of $6.04 million as of 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryWorkInProcessNetOfReserves · last filed 2020-11-06
- 2020-09-30: Inventory, Work in Process, Net of Reserves $6.04M.
- 2020-06-30: Inventory, Work in Process, Net of Reserves $3.51M.
- 2017-06-30: Inventory, Work in Process, Net of Reserves $1.30M.
- 2017-03-31: Inventory, Work in Process, Net of Reserves $655.00K.
| Period end | Inventory, Work in Process, Net of Reserves |
|---|---|
| 2020-09-30 | $6.04M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $3.51M 10-Q · filed 2020-08-07 |
| 2017-06-30 | $1.30M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $655.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $500.00K 10-Q · filed 2017-08-08 |
| 2016-09-30 | $2.23M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $1.95M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $1.95M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.61M 10-K · filed 2017-02-27 |
| 2014-12-31 | $267.00K 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |